BALTIMORE, MARYLAND – The Maryland Wholesale Medical Cannabis Trade Association (CANMD) released the following statement today regarding legislation to alter the membership of the Natalie M. LaPrade Medical Cannabis Committee and increase the number of growers that may be licensed by the Commission.
“Patients have waited long enough for access to these important medicines. Maryland has had one of the slowest rollouts of any state to implement a medical cannabis program, and we look forward to working with the Commission and the Maryland General Assembly to improve public health and patient access to ensure that there are no more delays in the State’s ability to provide this medicine to patients.
“Our Members have acted in good faith, participated in the double-blind application process designed by the State that was extensively publicly debated, reviewed and approved by the legislative committee charged with reviewing agency regulations. We have made significant investments in our business operations based on the State’s commitment that only 15 grower licenses would be awarded before a future market analysis was conducted. The Maryland General Assembly should not break its commitment and arbitrarily seek to increase the number of licenses at this early stage.”
The Maryland Wholesale Medical Cannabis Association (CANMD) is comprised of a diverse group of medical cannabis growers and processors in Maryland. Founding Members are growers and processors selected for preliminary approval to cultivate and process medical cannabis by the Natalie M. LaPrade Maryland Medical Cannabis Commission. CANMD advocates for laws, regulations and public policies that prioritize patient access and foster an accountable, consistent and innovative medical cannabis industry in Maryland.
CANMD Mission Statement:
The Maryland Wholesale Medical Cannabis Association (CANMD) promotes the responsible advancement of the medical cannabis industry in Maryland by fostering a favorable social, economic and legal climate. The catalysts for our work are improved public health, patient advocacy and the advancement of science. Providing a unified voice for medical cannabis growers and processors in Maryland, we support efforts to create transparency, accountability, and consistency in the state’s medical cannabis industry and strive to educate and act as a resource to lawmakers, medical providers and patients.